by Diana Caldwell | Sep 6, 2013
FDA final guidance entitled “Guidance for Industry Oversight of Clinical Investigations —A Risk-Based Approach to Monitoring,” was issued early August and is similar to the draft guidance published in 2011. FDA encourages risk based remote monitoring,...
by Diana Caldwell | Aug 23, 2013
Gretchen Miller Bowker, Pearl IRB COO, will be speaking on a panel at the upcoming ACS annual meeting. The high profile event will be held September 8 – 12th, 2013. To register and see the full agenda, click here. Date/time: ...
by Diana Caldwell | Aug 22, 2013
Indiana University’s Kelley School Center for the Business of Life Sciences is holding their next Life Science Series Collaboration series event on September 6, 2013. Pearl’s COO, Gretchen Bowker will be moderating the morning panel discussion. Pearl is a proud...
by Diana Caldwell | Feb 25, 2013
Pearl Pathways releases press release The diverse backgrounds of our new teammates serve growing demands of Pearl Pathways’ clients. FOR IMMEDIATE RELEASE INDIANAPOLIS, INDIANA –February 25, 2013- Pearl Pathways announces the recent hiring of Daphine Glowner,...
by Diana Caldwell | Jan 29, 2013
INDIANAPOLIS (Jan. 29, 2013) – Pearl IRB, LLC d/b/a Pearl Pathways, a life sciences product development and regulatory consultant company, announced plans today to expand its operations here, creating up to 38 new jobs by 2016. “Founded by Hoosier researchers and...